This two-day conference will serve as a platform to discuss compliance and transparency areas of key concern. Goal is to unravel compliance challenges, define and learn fair market value and develop a consistent, simple and transparent method and strategy for your company.
When QUALITY meets OPEX in manufacturing
PHARMA and Biotech leaders understand the importance of shifting from a culture of compliance to a culture of quality.
Times of transformation call for increasing overall quality and efficiency while lowering costs in order to follow regulations and maintain a competitive edge.
Can you sustain the leadership commitment and employee engagement required in the continuous improvement of quality? Do you know how to overcome resistance to change and successfully lead engaged employees who see the importance of the overall strategy?
On 22 – 23 September 2016, Vienna will be the place where Quality meets OPEX. Organized by Fleming., delegates will have the unique opportunity to attend two events in one and meet 100+ industry professionals under one roof.
At the 12th Annual Quality in Pharma & Biotech Forum, participants will discuss with leading experts how to translate a quality culture into operations and close the loop on their desired level of quality. They will gain insight into GMP inspection trends, data integrity requirements, quality metrics, Lean Six Sigma approach in a quality unit, CMO quality oversight, quality risk management in issue handling, serialization and technology transfer strategies.
The 12th Annual OPEX in Pharma & Biotech Forum will provide insights into developing defect-free processes. Attendees will find out how to achieve manufacturing excellence through more competitive improvement strategies in Digitalization, Six Sigma and advanced technologies such as 3D printing. Experts will explain how to lead initiatives even further, develop operating models in an autonomous work environment and create strong learning loops to adjust the operational excellence approach.
One day prior to the event, on 21 September, a pre-conference site visit to the facilities of Baxalta, one of the largest biopharma companies in Austria, will be prepared for interested participants.
Interested in this topic?
Project & Portfolio Management for Pharma and Biotech – EAST
For the upcoming Project and Portfolio Management for Pharma and Biotech Conference, Fleming presents a high-level meeting building on more than a decade of experience in running global Pharma PPM events worldwide.
Patient Adherence and Engagement
Discuss the issues of non-adherence with other stakeholders and find a solution together with the patients themselves.
Take a Good Look at the Future of Corporate Universities
There are four things corporate universities can do to avoid becoming irrelevant in the digital age.
Ready for the new GCP ICH E6 (R2) addendum?
On the 23rd of July 2015, the EMA's Committee for Human Medicinal Products released the Guideline for Good Clinical Practice E6(R2) for consultation. On the 14th of June 2017, it will come into effect and influence everyone involved in the clinical research process. What does it mean to pharma and biotech companies, sponsors, CROs, research institutes and third-party organizations?
With improved patient engagement to increased patient adherence
Chronic illnesses are commonly treated with the long-term use of medications. This treatment could be successful, however, its benefits are overshadowed by the fact that 50% of patients don't take their medications as prescribed. Reveal all the alarming numbers of non-adherence and learn how to decrease it with improved patient engagement.